Prevalence studies of BZD use vary according to the population sampled, but about 10% of the US older population use BZDs regularly, mostly for sedative and anxiolytic purposes.[3]Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med. 1998 Apr;13(4):243-50.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1496936
http://www.ncbi.nlm.nih.gov/pubmed/9565387?tool=bestpractice.com
This figure is as high as 36% for adults receiving treatment for depression in mental healthcare settings.[4]Valenstein M, Khanujua Taylor K, Austin K, et al. Benzodiazepine use among depressed patients treated in mental health settings. Am J Psychiatry. 2004 Apr;161(4):654-61.
http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.161.4.654
http://www.ncbi.nlm.nih.gov/pubmed/15056511?tool=bestpractice.com
BZDs are prescribed for 30% to 74% of patients with post-traumatic stress disorder (PTSD), despite research showing that BZDs are ineffective for the prevention and management of PTSD.[5]Guina J, Rossetter SR, DeRhodes BJ, et al. Benzodiazepines for PTSD: a systematic review and meta-analysis. J Psychiatr Pract. 2015 Jul;21(14):281-303.
http://www.ncbi.nlm.nih.gov/pubmed/26164054?tool=bestpractice.com
BZD use is higher in white people than in other ethnic groups. Twice as many females as males use BZDs. Sedatives, anxiolytics, and hypnotics are commonly prescribed for people in the sixth and seventh decades of life. Prevalence of BZD use has been reported as ranging from 3.9% in middle-aged and older adults in Brazil, to 35.9% in people ages 65 years and older in Canada.[6]Brunoni AR, Nunes MA, Figueiredo R, et al. Patterns of benzodiazepine and antidepressant use among middle-aged adults: the Brazilian longitudinal study of adult health (ELSA-Brasil). J Affect Disord. 2013 Oct;151(1):71-7.
http://www.ncbi.nlm.nih.gov/pubmed/23769607?tool=bestpractice.com
[7]Préville M, Vasiliadis HM, Bossé C, et al. Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: results from the longitudinal ESA study. Can J Psychiatry. 2011 Jun;56(6):348-57.
http://journals.sagepub.com/doi/abs/10.1177/070674371105600606?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
http://www.ncbi.nlm.nih.gov/pubmed/21756449?tool=bestpractice.com
There is evidence to suggest that among older people, with or without Alzheimer disease, BZD use may increase risk of stroke and hip fracture.[8]Saarelainen L, Tolppanen AM, Koponen M, et al. Risk of hip fracture in benzodiazepine users with and without Alzheimer disease. J Am Med Dir Assoc. 2017 Jan;18(1):87;e15-87;e21.
http://www.jamda.com/article/S1525-8610(16)30435-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/27847263?tool=bestpractice.com
[9]Taipale H, Koponen M, Tanskanen A, et al. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease. Int Clin Psychopharmacol. 2017 May;32(3):135-41.
http://www.ncbi.nlm.nih.gov/pubmed/28072593?tool=bestpractice.com
[10]Huang WS, Muo CH, Chang SN, et al. Benzodiazepine use and risk of stroke: a retrospective population-based cohort study. Psychiatry Clin Neurosci. 2014 Apr;68(4):255-62.
http://www.ncbi.nlm.nih.gov/pubmed/24829937?tool=bestpractice.com
Nonmedical use of BZDs is highest in people ages 18 to 25 years, with rates of 0.7% to 1.9%.[11]Buckley NA, Dawson AH, Whyte IM, et al. Relative toxicity of benzodiazepines in overdose. BMJ. 1995 Jan 28;310(6974):219-21.
http://www.bmj.com/cgi/content/full/310/6974/219
http://www.ncbi.nlm.nih.gov/pubmed/7866122?tool=bestpractice.com
Use is especially common in those who abuse alcohol, with up to 40% reporting inter-current or concurrent self-medication with BZDs.
With regard to illicit drug use, BZDs have largely replaced barbiturates, methaqualone, and glutethimide for sedation, anxiolysis, and inducing sleep. BZDs are preferred over older agents both medically and as recreational drugs because of the much greater safety profile and decreased risk of serious toxicity with overdose.[11]Buckley NA, Dawson AH, Whyte IM, et al. Relative toxicity of benzodiazepines in overdose. BMJ. 1995 Jan 28;310(6974):219-21.
http://www.bmj.com/cgi/content/full/310/6974/219
http://www.ncbi.nlm.nih.gov/pubmed/7866122?tool=bestpractice.com
Despite their safety, BZD overdose is now common, particularly with suicidal behavior and in conjunction with opioid abuse.[12]Warner M, Trinidad JP, Bastian BA, et al. Drugs most frequently involved in drug overdose deaths: United States, 2010-2014. Natl Vital Stat Rep. 2016 Dec;65(10):1-15.
https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_10.pdf
http://www.ncbi.nlm.nih.gov/pubmed/27996932?tool=bestpractice.com
BZDs account for approximately 31% of fatal overdoses involving prescription drugs in the US, while 75% of these fatal overdoses also involve opioids.[13]Bachhuber MA, Hennessy S, Cunningham CO, et al. Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013. Am J Public Health. 2016 Apr;106(4):686-8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816010
http://www.ncbi.nlm.nih.gov/pubmed/26890165?tool=bestpractice.com
Drug-related overdose deaths are increasing, with more than 106,000 individuals in the US dying from drug-induced overdose in 2021, compared with 52,000 in 2016.[14]National Institutes of Health, National Institute on Drug Abuse, and U.S. Department of Health and Human Services. Drug overdose death rates. Jun 2023 [internet publication].
https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
Of these 106,000, approximately 12,500 deaths were associated with BZD use.[14]National Institutes of Health, National Institute on Drug Abuse, and U.S. Department of Health and Human Services. Drug overdose death rates. Jun 2023 [internet publication].
https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates